Marcus & Millichap (MMI) Q2 2026 earnings review

Operating Leverage Arrives as Larger Deals Rebound

Marcus & Millichap extended its double-digit revenue recovery with a 17.8% YoY gain in Q2, crossing $202 million. Crucially, the company's operating leverage model is working: SG&A expenses remained completely flat, allowing the top-line beat to flow directly to the bottom line. Net Income swung to a positive $3.9 million from an $11 million loss a year ago, and Adjusted EBITDA surged to $12.1 million. The institutional segment (deals >$20M) flipped from a major headwind in 2025 to a growth leader. However, management warned that inflation and geopolitical tensions are keeping bid/ask spreads wide, meaning a complete market normalization will be a slow grind through the end of 2026.

🐂 Bull Case

Larger Transactions Have Recovered

The Middle Market and Larger Transaction Market segment accelerated to 29.4% YoY revenue growth. This segment was a significant drag throughout 2025, and its revival provides a massive boost to total brokerage volume.

Strict Cost Discipline

SG&A expenses were flat YoY at $71.7 million despite an 18% surge in revenue. This proves the company's prior investments in talent and technology are now scaling efficiently.

🐻 Bear Case

Gross Margin Squeeze

Cost of services ticked up 50 basis points to 62.4% of revenue. As senior brokers close more deals, they hit higher commission splits, capping the company's gross margin expansion.

Macro Headwinds Persist

Despite the strong print, management explicitly cited the Middle East conflict, inflation, and rate volatility as ongoing threats to bid/ask spreads, predicting challenges will extend through late 2026.

⚖️ Verdict: 🟢

Bullish. MMI proved it can control costs while riding a revenue rebound. Turning a deep net loss into a profit on the back of flat SG&A is exactly the operating leverage investors were waiting for.

Key Themes

DRIVER 🟢

Operating Leverage Materializes

Stable. The most important metric in this report isn't the 17.8% revenue growth—it is the 0.2% growth in SG&A. For the past two years, MMI defended high expenses as 'strategic investments' during a market downturn. That thesis is finally being vindicated. Revenue is scaling against a fixed cost base, driving a $10.6 million YoY improvement in Adjusted EBITDA.

DRIVER NEW 🟢

Institutional Buyers Are Back

Accelerating. The Middle Market and Larger Transaction Market (deals over $10M) was the standout performer. Revenue from this segment surged 29.4% to $54.7 million. This represents a stark reversal from mid-2025 when this segment was shrinking by 12%. Institutional clients who paused activity due to rate shocks are finally capitulating to new market pricing.

THEME

Financing Growth Remains Solid, But Moderating

Decelerating. The financing division (MMCC) remains a reliable growth engine, posting a 15.3% revenue increase to $30.3 million. However, this is a sequential deceleration from the massive 48% growth rate seen in Q1 2026. The average fee rate climbed slightly by 10 basis points YoY, offsetting softer volume growth.

CONCERN 🔴

Commission Tiers Squeezing Gross Margins

Stable. Cost of services as a percentage of revenue increased by 50 basis points to 62.4%. Management attributed this directly to senior investment sales and financing professionals earning higher commission splits as their production normalizes. This structural reality means that as the market recovers, top-tier producers will take a larger share of the revenue, limiting gross margin upside.

CONCERN 🔴

Macro Reality Check Contradicts the Blowout Numbers

Stable. Despite delivering nearly 18% top-line growth, management's commentary remained highly cautious. They explicitly flagged the resurgence of Middle East conflict and rising inflation pressures as active threats to bid/ask spreads. They are guiding for transaction market challenges to extend through the entirety of 2026, indicating this recovery is fragile and highly sensitive to external shocks.

DRIVER

Fortress Balance Sheet Fuels Shareholder Returns

Stable. MMI closed the quarter with $345 million in total cash and marketable securities and zero debt. The company continues to aggressively buy back stock, repurchasing 912,957 shares for $23.9 million in the first half of the year. With a freshly expanded $90.1 million remaining authorization and a $0.25 semi-annual dividend, management is heavily supporting the stock while waiting for M&A valuations to normalize.

Other KPIs

Private Client Market Revenue $106.2 million

Stable. MMI's core bread-and-butter segment grew 13.6% YoY, perfectly consistent with the 13.4% growth seen in Q1. This segment continues to be the bedrock of the firm, driven by local banks and credit unions providing liquidity to private investors.

Brokerage Sales Volume $9.49 billion

Accelerating. Total brokerage sales volume increased 18.4% YoY. This outpaced the 11.2% growth in total transaction count (1,530 vs 1,375), confirming that average deal sizes are increasing as larger institutional properties begin to trade again.

Guidance

Market Normalization Outlook Challenges extending through 2026

Stable. Management refrained from giving hard quantitative guidance but set a firm qualitative boundary: do not expect a total market normalization this year. They anticipate ongoing price discovery and wide bid/ask spreads to persist through the end of 2026, though they maintain long-term confidence in their consolidation strategy.

Key Questions

Commission Split Headwinds

Cost of services ticked up 50 basis points this quarter as senior producers hit higher tiers. If the transaction market continues to accelerate into the second half of the year, how high could this cost-of-services ratio climb?

Institutional Momentum Sustainability

The 29% growth in the Larger Transaction market is highly encouraging. Are these primarily legacy deals from 2025 finally closing, or are you seeing a genuinely new wave of institutional listings hitting the market?

Capital Allocation vs M&A

You repurchased nearly $24 million in stock in the first half of the year. Given the recent board authorization of an additional $70 million, has your appetite for M&A cooled due to valuation disagreements, shifting the priority entirely to buybacks?